Suppliers / zhejiang xianju pharmaceutical

zhejiang xianju pharmaceutical

United States 002332.SZ 146 employees Updated 9 July 2026

zhejiang xianju pharmaceutical is an API manufacturer based in United States. It holds 22 active US drug master files across a filed portfolio of 19 molecules.

22
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Dexamethasone SFDA (Saudi Arabia), US FDA 3
Prednisolone SFDA (Saudi Arabia), US FDA 3
Testosterone US FDA 3
Methylprednisolone SFDA (Saudi Arabia), US FDA 2
Rocuronium SFDA (Saudi Arabia), US FDA 2
Betamethasone US FDA 1
Brexanolone US FDA 1
Estradiol US FDA 1
Ethinylestradiol US FDA 1
Hydrocortisone US FDA 1
Show all 19 molecules on file
Levonorgestrel US FDA 1
Medroxyprogesterone Acetate US FDA 1
Megestrol Acetate US FDA 1
Mifepristone US FDA 1
Prednisone US FDA 1
Progesterone US FDA 1
Tiotropium US FDA 1
Triamcinolone US FDA 1
Vecuronium US FDA 1

Also appears on these molecule pages

Show 1 more molecule pages

Comparing suppliers?

Choose your molecules and target markets. zhejiang xianju pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability